Many of the AD risk genes show highest expression in glia, i.e. astrocytes (e.g. APOE, CLU, SORL1) or microglia (e.g. TREM2, CD33) [28] highlighting the importance of glia, especially microglia and astrocytes, for AD pathophysiology. This evidence concerns the gene CD33 and Alzheimer disease.